Annual CFO
-$163.69 M
+$5.86 M+3.46%
December 31, 2023
Summary
- As of February 7, 2025, LYEL annual cash flow from operations is -$163.69 million, with the most recent change of +$5.86 million (+3.46%) on December 31, 2023.
- During the last 3 years, LYEL annual CFO has fallen by -$2.82 million (-1.75%).
- LYEL annual CFO is now -514.69% below its all-time high of $39.47 million, reached on December 31, 2019.
Performance
LYEL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$35.04 M
+$3.05 M+8.01%
September 30, 2024
Summary
- As of February 7, 2025, LYEL quarterly cash flow from operations is -$35.04 million, with the most recent change of +$3.05 million (+8.01%) on September 30, 2024.
- Over the past year, LYEL quarterly CFO has increased by +$5.59 million (+13.76%).
- LYEL quarterly CFO is now -62.02% below its all-time high of -$21.63 million, reached on September 30, 2020.
Performance
LYEL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$155.79 M
+$2.64 M+1.67%
September 30, 2024
Summary
- As of February 7, 2025, LYEL TTM cash flow from operations is -$155.79 million, with the most recent change of +$2.64 million (+1.67%) on September 30, 2024.
- Over the past year, LYEL TTM CFO has increased by +$7.91 million (+4.83%).
- LYEL TTM CFO is now -560.34% below its all-time high of -$23.59 million, reached on March 31, 2020.
Performance
LYEL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LYEL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.5% | +13.8% | +4.8% |
| 3 y3 years | -1.8% | -5.5% | -23.4% |
| 5 y5 years | -514.7% | -3.2% | -34.4% |
LYEL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.7% | +3.5% | -5.5% | +26.8% | -23.4% | +8.1% |
| 5 y | 5-year | -514.7% | +3.5% | -62.0% | +60.6% | -560.3% | +8.8% |
| alltime | all time | -514.7% | +3.5% | -62.0% | +60.6% | -560.3% | +8.8% |
Lyell Immunopharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$35.04 M(-8.0%) | -$155.79 M(-1.7%) |
| Jun 2024 | - | -$38.09 M(-9.3%) | -$158.43 M(-0.7%) |
| Mar 2024 | - | -$42.02 M(+3.4%) | -$159.50 M(-2.6%) |
| Dec 2023 | -$163.69 M(-3.5%) | -$40.63 M(+7.8%) | -$163.69 M(+0.2%) |
| Sep 2023 | - | -$37.69 M(-3.8%) | -$163.33 M(+0.4%) |
| Jun 2023 | - | -$39.16 M(-15.3%) | -$162.74 M(-3.1%) |
| Mar 2023 | - | -$46.21 M(+14.8%) | -$167.91 M(-1.0%) |
| Dec 2022 | -$169.56 M | -$40.27 M(+8.5%) | -$169.56 M(+4.3%) |
| Sep 2022 | - | -$37.10 M(-16.3%) | -$162.50 M(+7.7%) |
| Jun 2022 | - | -$44.33 M(-7.4%) | -$150.89 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$47.85 M(+44.1%) | -$140.50 M(+11.3%) |
| Dec 2021 | -$126.25 M(-21.5%) | -$33.21 M(+30.3%) | -$126.25 M(+5.4%) |
| Sep 2021 | - | -$25.49 M(-24.9%) | -$119.77 M(+3.3%) |
| Jun 2021 | - | -$33.95 M(+1.0%) | -$115.90 M(-32.2%) |
| Mar 2021 | - | -$33.60 M(+25.7%) | -$170.88 M(+6.2%) |
| Dec 2020 | -$160.87 M(-507.5%) | - | - |
| Dec 2020 | - | -$26.73 M(+23.6%) | -$160.87 M(+19.9%) |
| Sep 2020 | - | -$21.63 M(-75.7%) | -$134.14 M(+19.2%) |
| Jun 2020 | - | -$88.92 M(+276.9%) | -$112.51 M(+376.9%) |
| Mar 2020 | - | -$23.59 M | -$23.59 M |
| Dec 2019 | $39.47 M | - | - |
FAQ
- What is Lyell Immunopharma annual cash flow from operations?
- What is the all time high annual CFO for Lyell Immunopharma?
- What is Lyell Immunopharma annual CFO year-on-year change?
- What is Lyell Immunopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly CFO year-on-year change?
- What is Lyell Immunopharma TTM cash flow from operations?
- What is the all time high TTM CFO for Lyell Immunopharma?
- What is Lyell Immunopharma TTM CFO year-on-year change?
What is Lyell Immunopharma annual cash flow from operations?
The current annual CFO of LYEL is -$163.69 M
What is the all time high annual CFO for Lyell Immunopharma?
Lyell Immunopharma all-time high annual cash flow from operations is $39.47 M
What is Lyell Immunopharma annual CFO year-on-year change?
Over the past year, LYEL annual cash flow from operations has changed by +$5.86 M (+3.46%)
What is Lyell Immunopharma quarterly cash flow from operations?
The current quarterly CFO of LYEL is -$35.04 M
What is the all time high quarterly CFO for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly cash flow from operations is -$21.63 M
What is Lyell Immunopharma quarterly CFO year-on-year change?
Over the past year, LYEL quarterly cash flow from operations has changed by +$5.59 M (+13.76%)
What is Lyell Immunopharma TTM cash flow from operations?
The current TTM CFO of LYEL is -$155.79 M
What is the all time high TTM CFO for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM cash flow from operations is -$23.59 M
What is Lyell Immunopharma TTM CFO year-on-year change?
Over the past year, LYEL TTM cash flow from operations has changed by +$7.91 M (+4.83%)